News Release 

Alliance for Cancer Gene Therapy announces Summit 2021 be there when the next breakthroughs happens

Join world renowned cancer researchers as they gather to discuss latest advances in cancer cell and gene therapy for solid tumors

Alliance for Cancer Gene Therapy

Scientific Meeting Announcement

Alliance for Cancer Gene Therapy wants to change the C-word from Cancer to Cure -- building on the life changing success of CAR-T therapies for blood cancers, the organization is now focused on the urgent need to translate this success into therapies to fight more types of cancer, such as solid tumor cancers.

On April 29, 2021, the organization is bringing together the world's most renowned scientists and companies who are driving the latest advances in cancer cell and gene therapy for solid tumors to the Alliance for Cancer Gene Therapy Summit 2021.

The Summit 2021 will be held online on Thursday, April 29, 2021, from 10:00 a.m. until 6:00 p.m (ET), and provides the unique opportunity to connect with leading researchers developing the next generation cancer cell and gene therapies, biotech companies who are bringing new treatments through the clinic, and investors who are funding this burgeoning pipeline of solid tumors breakthroughs. A total of eight panels will discuss advances in solid tumor therapies with featured panels tackling the greatest challenges in hard-to-treat cancers like pancreatic cancer and glioblastoma, a brain cancer.

"It's so rare to have the opportunity to hear from the world's top cancer researchers, biotechs, investors and patients all in the same room," noted Barbara Lavery, chief program officer for Alliance for Cancer Gene Therapy. "We're excited to have Alliance for Cancer Gene Therapy be the catalyst for these important conversations that will help not only other scientists working on new cell and gene therapy approaches, but companies seeking investment to advance their clinical pipelines, and patients and their families looking for potentially life changing therapeutic options in their fight against cancer."

The day wraps up with a keynote presentation titled, "Does Cancer Have a Future?" with Nobel Prize Laureate James P. Allison, PhD, University of Pennsylvania's Carl H. June, MD, who is a TIME magazine person of the year, and Pulitzer Prize winning author and oncologist Siddhartha Mukherjee, MD, author of The Emperor of All Maladies. To learn more, see the list of speakers and panels and register for the event, visit the website Alliance for Cancer Gene Therapy Summit 2021.


Alliance for Cancer Gene Therapy

Alliance for Cancer Gene Therapy was founded in 2001 and became one of the first and only funding agencies to embrace a progressive vision for the underfunded but exceptionally promising discipline of cancer cell and gene therapy. The organization quickly became a catalytic force in shaping entirely new cancer treatment models by identifying, funding, and advancing the most innovative and impactful translational research in cell and gene therapies. To date, Alliance for Cancer Gene Therapy has awarded $30.7 million in grants to world class cancer researchers representing the top medical institutions in the U.S. and Canada, advancing new approaches to leukemia, lymphoma, ovarian, prostate, sarcoma, glioblastoma, melanoma, lung and pancreatic cancers. 100% of all public funds raised by Alliance for Cancer Gene Therapy directly supports research and programs. For more information, visit, call 203-358-5055, or join the Alliance for Cancer Gene Therapy community on Facebook, Twitter, LinkedIn and YouTube.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.